These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Enhanced in vitro and in vivo therapeutic efficacy of codrug-loaded nanoparticles against liver cancer. Li X, Xu H, Dai X, Zhu Z, Liu B, Lu X. Int J Nanomedicine; 2012; 7():5183-90. PubMed ID: 23055730 [Abstract] [Full Text] [Related]
31. In vitro human plasma distribution of nanoparticulate paclitaxel is dependent on the physicochemical properties of poly(ethylene glycol)-block-poly(caprolactone) nanoparticles. Letchford K, Liggins R, Wasan KM, Burt H. Eur J Pharm Biopharm; 2009 Feb; 71(2):196-206. PubMed ID: 18762253 [Abstract] [Full Text] [Related]
33. Characterization of the Uptake Efficiency and Cytotoxicity of Tetrandrine-Loaded Poly(N-vinylpyrrolidone)-Block-Poly(ε-caprolactone) (PVP-b-PCL) Nanoparticles in the A549 Lung Adenocarcinoma Cell Line. Xu H, Li X, Kong H, Zeng X, Jin Y, Qi Y, Wang H, Xie W. J Biomed Nanotechnol; 2016 Aug; 12(8):1699-707. PubMed ID: 29342348 [Abstract] [Full Text] [Related]
34. Anticancer effect and mechanism of polymer micelle-encapsulated quercetin on ovarian cancer. Gao X, Wang B, Wei X, Men K, Zheng F, Zhou Y, Zheng Y, Gou M, Huang M, Guo G, Huang N, Qian Z, Wei Y. Nanoscale; 2012 Nov 21; 4(22):7021-30. PubMed ID: 23044718 [Abstract] [Full Text] [Related]
35. In vitro and in vivo effect of paclitaxel and cepharanthine co-loaded polymeric nanoparticles in gastric cancer. Yu HH, Mi WN, Liu B, Zhao HP. J BUON; 2016 Nov 21; 21(1):125-34. PubMed ID: 27061540 [Abstract] [Full Text] [Related]
36. Paclitaxel-induced apoptosis is blocked by camptothecin in human breast and pancreatic cancer cells. Jeansonne DP, Koh GY, Zhang F, Kirk-Ballard H, Wolff L, Liu D, Eilertsen K, Liu Z. Oncol Rep; 2011 May 21; 25(5):1473-80. PubMed ID: 21331447 [Abstract] [Full Text] [Related]
37. Facile preparation of paclitaxel loaded silk fibroin nanoparticles for enhanced antitumor efficacy by locoregional drug delivery. Wu P, Liu Q, Li R, Wang J, Zhen X, Yue G, Wang H, Cui F, Wu F, Yang M, Qian X, Yu L, Jiang X, Liu B. ACS Appl Mater Interfaces; 2013 Dec 11; 5(23):12638-45. PubMed ID: 24274601 [Abstract] [Full Text] [Related]
38. Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells. Hu Y, Xie J, Tong YW, Wang CH. J Control Release; 2007 Mar 12; 118(1):7-17. PubMed ID: 17241684 [Abstract] [Full Text] [Related]